RESUMEN
OBJECTIVE: To report genome-wide cell-free DNA (cfDNA) screening facilitating the diagnosis of Pallister-Killian syndrome (PKS). METHODS: This is a retrospective cohort analysis of positive genome-wide cfDNA screening results showing increased signal from chromosome 12 and the detection of PKS. The genome-wide cfDNA screening results and the subsequent investigations were reviewed. RESULTS: Three singleton pregnancies (3/29007) from 2016 to 2017 yielded positive results indicating large gains on the entire p-arm of chromosome 12. In two cases, multiple structural abnormalities were detected by prenatal ultrasound and the couples opted for termination of pregnancy. Chromosomal microarray performed on fetal skin tissues of the two abortuses detected mosaic tetrasomy 12p, consistent with PKS. In the third case, karyotype and chromosomal microarray performed on an amniotic fluid sample also showed mosaic tetrasomy 12p. In each of the three cases, genome-wide cfDNA screening revealed a large gain on chromosome 12p; subsequent prenatal or postnatal diagnostic testing confirmed the diagnosis of PKS. CONCLUSION: We report the ability of genome-wide cfDNA screening to provide early suspicion and facilitate the subsequent genetic diagnosis of PKS. As genome-wide cfDNA screening becomes increasingly available, incidental diagnosis of partial aneuploidies is expected to increase.
Asunto(s)
Ácidos Nucleicos Libres de Células/análisis , Trastornos de los Cromosomas/diagnóstico , Hibridación Genómica Comparativa , Diagnóstico Prenatal/métodos , Adulto , China/epidemiología , Trastornos de los Cromosomas/epidemiología , Trastornos de los Cromosomas/genética , Cromosomas Humanos Par 12/genética , Estudios de Cohortes , Hibridación Genómica Comparativa/métodos , Hibridación Genómica Comparativa/estadística & datos numéricos , Femenino , Pruebas Genéticas/métodos , Pruebas Genéticas/estadística & datos numéricos , Humanos , Recién Nacido , Masculino , Análisis por Micromatrices/métodos , Valor Predictivo de las Pruebas , Embarazo , Diagnóstico Prenatal/estadística & datos numéricos , Estudios Retrospectivos , Adulto JovenRESUMEN
BACKGROUND: Preterm birth is the leading cause of neonatal death and handicap in survivors. Although twins are found in 1.5% of pregnancies they account for about 25% of preterm births. Randomized controlled trials in singleton pregnancies reported that the prophylactic use of progestogens, cervical cerclage and cervical pessary reduce significantly the rate of early preterm birth. In twin pregnancies, progestogens and cervical cerclage have been shown to be ineffective in reducing preterm birth. OBJECTIVE: The objective of this study was to test the hypothesis that the insertion of a cervical pessary in twin pregnancies would reduce the rate of spontaneous early preterm birth. STUDY DESIGN: This was a multicenter, randomized controlled trial in unselected twin pregnancies of cervical pessary placement from 20(+0)-24(+6) weeks' gestation until elective removal or delivery vs. expectant management. Primary outcome was spontaneous birth <34 weeks. Secondary outcomes included perinatal death and a composite of adverse neonatal outcomes (intraventricular haemorrhage, respiratory distress syndrome, retinopathy of prematurity or necrotizing enterocolitis) or need for neonatal therapy (ventilation, phototherapy, treatment for proven or suspected sepsis, or blood transfusion). Analysis was by intention to treat. This trial is registered in the ISRCTN registry, number 01096902. RESULTS: A total of 1,180 (56.0%) of the 2,107 eligible women agreed to take part in the trial; 590 received cervical pessary and 590 had expectant management. Two of the former and one of the latter were lost to follow up. There were no significant differences between the pessary and control groups in rates of spontaneous birth <34 weeks (13.6% vs. 12.9%; relative risk 1.054, 95% confidence interval [CI] 0.787-1.413; p=0.722), perinatal death (2.5% vs. 2.7%; relative risk 0.908, 95% CI 0.553-1.491; p=0.702), adverse neonatal outcome (10.0 vs. 9.2%; relative risk 1.094, 95% CI 0.851-1.407; p=0.524) or neonatal therapy (17.9% vs. 17.2%; relative risk 1.040, 95% CI 0.871-1.242; p=0.701). A post hoc subgroup analysis of 214 women with short cervix (≤25 mm) showed no benefit from the insertion of a cervical pessary. CONCLUSION: In women with twin pregnancy, routine treatment with cervical pessary does not reduce the rate of spontaneous early preterm birth.
Asunto(s)
Pesarios , Embarazo Gemelar , Nacimiento Prematuro/prevención & control , Adulto , Cuello del Útero/diagnóstico por imagen , Enterocolitis Necrotizante/prevención & control , Femenino , Humanos , Recién Nacido , Análisis de Intención de Tratar , Hemorragias Intracraneales/prevención & control , Muerte Perinatal/prevención & control , Embarazo , Síndrome de Dificultad Respiratoria del Recién Nacido/prevención & control , Retinopatía de la Prematuridad/prevención & control , Ultrasonografía , Espera VigilanteRESUMEN
Pseudoamniotic band syndrome (PABS) is a rare iatrogenic complication that arises after invasive procedures in monochorionic twins. We report 3 cases of PABS, 2 after fetoscopic laser photocoagulation and 1 after bipolar cord coagulation. Two cases were detected antenatally by ultrasound; out of the two, one underwent successful fetoscopic release of amniotic band, which is the first report in twin pregnancy to our knowledge. In our centre, the incidence of PABS was found to be 2%. There were 25 cases of PABS reported previously, of which 12 cases with clinical details were reviewed together with our 3 cases. The fetal limbs were involved in all 15 cases, leading to constriction or amputation. The umbilical cord was involved in 2 cases, resulting in fetal death in one and pregnancy termination in the other. Antenatal detection of PABS is rare (27%; 4/15) as this requires a high index of suspicion. Serial postoperative targeted ultrasound surveillance of the fetal limbs and umbilical cord is necessary, particularly when features of septostomy or chorioamniotic membrane separation are found. Colour Doppler examination for the perfusion of the affected limb should be performed when PABS is detected. Fetoscopic release of amniotic band could salvage the fetal limb from amputation when impaired blood flow is detected.
Asunto(s)
Síndrome de Bandas Amnióticas/diagnóstico por imagen , Transfusión Feto-Fetal/cirugía , Fotocoagulación/efectos adversos , Complicaciones Posoperatorias , Adulto , Síndrome de Bandas Amnióticas/etiología , Síndrome de Bandas Amnióticas/patología , Síndrome de Bandas Amnióticas/cirugía , Femenino , Muerte Fetal , Transfusión Feto-Fetal/complicaciones , Fetoscopía/efectos adversos , Humanos , Recién Nacido , Coagulación con Láser , Embarazo , Embarazo Gemelar , Síndrome , Ultrasonografía PrenatalRESUMEN
OBJECTIVE: The objective of this study is to assess the performance of noninvasive prenatal testing for trisomies 21 and 18 on the basis of massively parallel sequencing of cell-free DNA from maternal plasma in twin pregnancies. METHOD: A double-blind study was performed over 12 months. A total of 189 pregnant women carrying twins were recruited from seven hospitals. Maternal plasma DNA sequencing was performed to detect trisomies 21 and 18. The fetal karyotype was used as gold standard to estimate the sensitivity and specificity of sequencing-based noninvasive prenatal test. RESULTS: There were nine cases of trisomy 21 and two cases of trisomy 18 confirmed by karyotyping. Plasma DNA sequencing correctly identified nine cases of trisomy 21 and one case of trisomy 18. The discordant case of trisomy 18 was an unusual case of monozygotic twin with discordant fetal karyotype (one normal and the other trisomy 18). The sensitivity and specificity of maternal plasma DNA sequencing for fetal trisomy 21 were both 100% and for fetal trisomy 18 were 50% and 100%, respectively. CONCLUSION: Our study further supported that sequencing-based noninvasive prenatal testing of trisomy 21 in twin pregnancies could be achieved with a high accuracy, which could effectively avoid almost 95% of invasive prenatal diagnosis procedures.
Asunto(s)
ADN/análisis , Síndrome de Down/diagnóstico , Feto/química , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Cariotipo , Embarazo Gemelar/sangre , Análisis de Secuencia de ADN/métodos , Trisomía/diagnóstico , Adolescente , Adulto , Cromosomas Humanos Par 18 , ADN/sangre , Método Doble Ciego , Síndrome de Down/sangre , Femenino , Edad Gestacional , Humanos , Embarazo , Diagnóstico Prenatal/métodos , Sensibilidad y Especificidad , Síndrome de la Trisomía 18 , Adulto JovenRESUMEN
The stromal cell-derived factor-1 (SDF-1)/chemokine C-X-C receptor 4 (CXCR4) axis plays a critical role in homing and engraftment of hematopoietic stem/progenitor cells (HSCs) during bone marrow transplantation. To investigate the transcriptional regulation provided by this axis, we performed the first differential transcriptome profiling of human cord blood CD34(+) cells in response to short-term exposure to SDF-1 and identified a panel of genes with putative homing functions. We demonstrated that CD9, a member of the tetraspanin family of proteins, was expressed in CD34(+)CD38(-/lo) and CD34(+)CD38(+) cells. CD9 levels were enhanced by SDF-1, which simultaneously down-regulated CXCR4 membrane expression. Using specific inhibitors and activators, we demonstrated that CD9 expression was modulated via CXCR4, G-protein, protein kinase C, phospholipase C, extracellular signal-regulated kinase, and Janus kinase 2 signals. Pretreatment of CD34(+) cells with the anti-CD9 monoclonal antibody ALB6 significantly inhibited SDF-1-mediated transendothelial migration and calcium mobilization, whereas adhesion to fibronectin and endothelial cells was enhanced. Pretreatment of CD34(+) cells with ALB6 significantly impaired their homing to bone marrow and spleen of sublethally irradiated NOD/SCID (nonobese diabetic/severe combined immune-deficient) mice. Sorted CD34(+)CD9(-) cells displayed lower bone marrow homing capacity compared with that of total CD34(+) cells. CD9 expression on homed CD34(+) cells was significantly up-regulated in vivo. Our results indicate that CD9 might possess specific functions in HSC homing.
Asunto(s)
Antígenos CD/fisiología , Sangre Fetal/citología , Células Madre Hematopoyéticas/inmunología , Células Madre Hematopoyéticas/fisiología , Glicoproteínas de Membrana/fisiología , Animales , Anticuerpos Neutralizantes , Antígenos CD/genética , Antígenos CD34/metabolismo , Adhesión Celular/inmunología , Adhesión Celular/fisiología , Movimiento Celular/inmunología , Movimiento Celular/fisiología , Quimiocina CXCL12/farmacología , Perfilación de la Expresión Génica , Trasplante de Células Madre Hematopoyéticas , Células Madre Hematopoyéticas/efectos de los fármacos , Humanos , Técnicas In Vitro , Glicoproteínas de Membrana/antagonistas & inhibidores , Glicoproteínas de Membrana/genética , Ratones , Ratones Endogámicos NOD , Ratones SCID , Análisis de Secuencia por Matrices de Oligonucleótidos , Receptores CXCR4/fisiología , Transducción de Señal , Tetraspanina 29 , Trasplante HeterólogoRESUMEN
Uniparental disomy (UPD) is an uncommon chromosome condition, but UPD involving chromosome 21 is rarely reported. We reported here a case who had first trimester screening test for Down syndrome, chorionic villus sampling for fetal karyotyping, quantitative fluorescence polymerase chain reaction (QF-PCR), as well as non-invasive prenatal testing (NIPT) by maternal plasma sequencing. There were discordant results between fetal karyotyping and NIPT due to UPD 21combined with confined placental mosaicism of trisomy 21. This demonstrated that it is possible to detect placental mosaicism by NIPT, but further studies are required to confirm its sensitivity. Therefore, all positive NIPT results must be confirmed by conventional invasive test and karyotyping. QF-PCR has the additional benefit in diagnosing UPD.
Asunto(s)
Cromosomas Humanos Par 21/genética , Cariotipificación/métodos , Diagnóstico Prenatal/métodos , Análisis de Secuencia de ADN/métodos , Disomía Uniparental/diagnóstico , Adulto , Compensación de Dosificación (Genética)/fisiología , Femenino , Humanos , Mosaicismo , Embarazo/sangre , Trisomía/diagnóstico , Trisomía/genética , Disomía Uniparental/genéticaRESUMEN
OBJECTIVE: To evaluate the role of live xPlane imaging of ductal arch view in detection of fetal conotruncal anomalies. METHODS: Two hundred selected singleton pregnancies, including 152 normal cases, 27 conotruncal anomalies and 21 other types of fetal heart abnormalities were enrolled in this observational study. All the cases were scanned to visualize the ductal arch view with live xPlane imaging by a single observer. The detection rate of conotruncal and non-conotruncal anomalies with live xPlane imaging was compared. RESULTS: In using this new method of live xPlane imaging, an abnormal ductal arch view was visualized in 92.6% of fetal conotruncal anomalies, compared with that of non-conotruncal anomalies (23.8%, p < 0.001). CONCLUSION: The ductal arch view can be obtained by live xPlane imaging. This method is relatively simple and feasible, hence may be a useful tool to detect fetal conotruncal anomalies.
Asunto(s)
Ecocardiografía Tridimensional/métodos , Corazón Fetal/diagnóstico por imagen , Cardiopatías Congénitas/diagnóstico por imagen , Ultrasonografía Prenatal/métodos , Adulto , Índice de Masa Corporal , Sistemas de Computación , Femenino , Corazón Fetal/anomalías , Edad Gestacional , Humanos , Embarazo , Adulto JovenRESUMEN
OBJECTIVE: To report secondary or additional findings arising from introduction of non-invasive prenatal testing (NIPT) for aneuploidy by whole genome sequencing as a clinical service. METHODS: Five cases with secondary findings were reviewed. RESULTS: In Case 1, NIPT revealed a large duplication in chromosome 18p, which was supported by arrayCGH of amniocyte DNA, with final karyotype showing mosaic tetrasomy 18p. In Case 2, a deletion in the proximal long arm of chromosome 18 of maternal origin was suspected and confirmed by arrayCGH of maternal white cell DNA. In Case 3, NIPT was negative for trisomies 21 and 18. In-depth analysis for deletions/duplications was requested when fetal structural anomalies were detected at routine scan. A deletion in the proximal long arm of chromosome 3 was found and confirmed by karyotyping. In Case 4, NIPT correctly predicted confined placental mosaicism with triple trisomy involving chromosomes X, 7 and 21. In Case 5, NIPT correctly detected a previously unknown maternal mosaicism for 45X. CONCLUSION: Non-invasive prenatal testing is able to detect a wide range of fetal, placental and maternal chromosomal abnormalities. This has important implications on patient counseling when an abnormality is detected by NIPT.
Asunto(s)
Aneuploidia , Cromosomas Humanos Par 21/genética , Síndrome de Down/diagnóstico , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Diagnóstico Prenatal/métodos , Trisomía/diagnóstico , Adulto , Cromosomas Humanos Par 18 , Cromosomas Humanos X/genética , Servicios de Laboratorio Clínico , ADN/sangre , ADN/genética , Reacciones Falso Negativas , Femenino , Feto/metabolismo , Humanos , EmbarazoRESUMEN
OBJECTIVE: To report the feasibility of fetal chromosomal deletion/duplication detection using a novel bioinformatic method of low coverage whole genome sequencing of maternal plasma. METHOD: A practical method Fetal Copy-number Analysis through Maternal Plasma Sequencing (FCAPS), integrated with GC-bias correction, binary segmentation algorithm and dynamic threshold strategy, was developed to detect fetal chromosomal deletions/duplications of >10 Mb by low coverage whole genome sequencing (about 0.08-fold). The sensitivity/specificity of the resultant FCAPS algorithm in detecting deletions/duplications was firstly assessed in silico and then tested in 1311 maternal plasma samples from those with known G-banding karyotyping results of the fetus. RESULTS: Deletions/duplications, ranged from 9.01 to 28.46 Mb, were suspected in four of the 1311 samples, of which three were consistent with the results of fetal karyotyping. In one case, the suspected abnormality was not confirmed by karyotyping, representing a false positive case. No false negative case was observed in the remaining 1307 low-risk samples. The sensitivity and specificity for detection of >10-Mb chromosomal deletions/duplications were100% and 99.92%, respectively. CONCLUSION: Our study demonstrated FCAPS has the potential to detect fetal large deletions/duplications (>10 Mb) with low coverage maternal plasma DNA sequencing currently used for fetal aneuploidy detection.
Asunto(s)
Aneuploidia , Duplicación de Gen , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Diagnóstico Prenatal/métodos , Eliminación de Secuencia , Adulto , Algoritmos , Secuencia de Bases , ADN/sangre , ADN/metabolismo , Femenino , Feto/metabolismo , Edad Gestacional , Humanos , Embarazo/sangre , Sensibilidad y EspecificidadRESUMEN
OBJECTIVE: To determine the effectiveness of cerclage pessary in the prevention of preterm birth in asymptomatic Chinese women with a short cervix at 20 to 24 weeks. METHODS: Low-risk women carrying singleton pregnancies were screened with transvaginal ultrasound, and those with a cervical length <25 mm at 20 to 24 weeks were recruited into a randomized controlled trial, comparing the prophylactic use of cerclage pessary with expectant management. The analysis was by intent-to-treat. The primary outcome measure was preterm delivery before 34 weeks. RESULTS: Among 4438 screened women, 203 women (4.6%) met the inclusion criteria and 108 (58%) consented for the study. A total of 53 and 55 women were allocated to pessary and control groups, respectively. There was no difference in background demographics, including the mean cervical length (19.6 mm versus 20.5 mm) and the mean gestational age at randomization (both 21.9 weeks). Delivery before 34 weeks occurred in 9.4% and 5.5% (p = 0.46) in the pessary and the control groups, respectively. No differences in major side effects were noted between the groups. CONCLUSION: In our population, <5% had a cervical length of less than 25 mm at 20 to 24 weeks' gestation. The prophylactic use of cerclage pessary did not reduce the rate of preterm delivery before 34 weeks.
Asunto(s)
Cerclaje Cervical/métodos , Resultado del Embarazo , Nacimiento Prematuro/prevención & control , Ultrasonografía Prenatal , Incompetencia del Cuello del Útero/terapia , Adulto , Intervalos de Confianza , Femenino , Humanos , Recién Nacido , Estimación de Kaplan-Meier , Edad Materna , Paridad , Pesarios , Embarazo , Segundo Trimestre del Embarazo , Estudios Prospectivos , Valores de Referencia , Medición de Riesgo , Incompetencia del Cuello del Útero/diagnóstico por imagen , Adulto JovenRESUMEN
OBJECTIVE: To evaluate the perinatal outcome of monochorionic (MC) multiple pregnancies after selective reduction by radiofrequency ablation (RFA). METHODS: A case series of all MC multiple pregnancies with selective reduction by RFA in one single institution was reviewed. RESULTS: Ten consecutive patients with an MC pregnancy (9 pairs of twins and 1 set of triplets) underwent RFA. The median gestational age at the time of the procedure was 15.6 weeks (range, 12.3-19.6). The indications for selective reduction included discordance for fetal anomalies (4 cases), twin reversed arterial perfusion sequence (3 cases), selective intrauterine growth restriction (2 cases) and severe twin-twin transfusion syndrome (1 case). All procedures were technically successful in achieving selective reduction. The overall survival rate of the co-twin was 81.8% (9/11), and the median gestational age at delivery was 35.9 weeks (range, 32.4-38.6). There was one preterm delivery before 34 weeks of gestation (11.1%). Preterm premature rupture of the membranes occurred in 2 patients (20%); however, this was not observed within 4 weeks postoperatively, nor did they deliver before 32 weeks. CONCLUSIONS: RFA is a promising technique for selective reduction in complicated MC multiple pregnancies with a high survival rate and low complication rate.
Asunto(s)
Complicaciones del Embarazo/cirugía , Reducción de Embarazo Multifetal/métodos , Embarazo Múltiple , Adulto , Femenino , Transfusión Feto-Fetal/cirugía , Edad Gestacional , Humanos , Recién Nacido , Masculino , Embarazo , Resultado del Embarazo , Embarazo Triple , Embarazo Gemelar , Terapia por Radiofrecuencia , Estudios Retrospectivos , Gemelos Monocigóticos , Cordón Umbilical/cirugíaRESUMEN
OBJECTIVE: To report the performance of massively parallel sequencing (MPS) based prenatal noninvasive fetal trisomy test based on cell-free DNA sequencing from maternal plasma in a routine clinical setting in China. METHOD: The MPS-based test was offered as a prenatal screening test for trisomies 21 and 18 to pregnant women in 49 medical centers over 2 years. A total of 11,263 participants were recruited and the MPS-based test was performed in 11,105 pregnancies. Fetal outcome data were obtained after the expected date of confinement. RESULTS: One hundred ninety cases were classified as positive, including 143 cases of trisomy 21 and 47 cases of trisomy 18. With the karyotyping results and the feedback of fetal outcome data, we observed one false positive case of trisomy 21, one false positive case of trisomy 18 and no false negative cases, indicating 100% sensitivity and 99.96% specificity for the detection of trisomies 21 and 18. CONCLUSION: Our large-scale multicenter study proved that the MPS-based test is of high sensitivity and specificity in detecting fetal trisomies 21 and 18. The introduction of this screening test into a routine clinical setting could avoid about 98% of invasive prenatal diagnostic procedures.
Asunto(s)
Cromosomas Humanos Par 18 , Síndrome de Down/diagnóstico , Secuenciación de Nucleótidos de Alto Rendimiento , Pruebas de Detección del Suero Materno , Trisomía/diagnóstico , Adolescente , Adulto , China/epidemiología , Síndrome de Down/epidemiología , Reacciones Falso Positivas , Femenino , Humanos , Persona de Mediana Edad , Embarazo , Estudios Prospectivos , Sensibilidad y Especificidad , Análisis de Secuencia de ADN , Flujo de Trabajo , Adulto JovenRESUMEN
OBJECTIVE: To assess the value of spectral karyotyping (SKY) combined with microarray-based comparative genomic hybridization (array-CGH) for the diagnosis of complex ring chromosome aberration. METHODS: For an 8-year-old boy featuring growth retardation, G-banding analysis has indicated a 46,XY,r(15)? karyotype, which was delineated by SKY in combination with array-CGH. RESULTS: The ring chromosome has originated from chromosome 15 according to SKY analysis. Position of the breakpoint (15q26.3) and a 594 kb deletion were revealed by array-CGH. CONCLUSION: Molecular cytogenetic technologies are efficient tools for clarifying complex chromosomal abnormality, which has provided a powerful tool for conventional cytogenetic analysis.
Asunto(s)
Hibridación Genómica Comparativa/métodos , Cromosomas en Anillo , Cariotipificación Espectral , Niño , Cromosomas Humanos Par 15 , Humanos , Masculino , Mosaicismo , Análisis de Secuencia por Matrices de OligonucleótidosRESUMEN
OBJECTIVE: To evaluate the clinical effect of fetoscopic laser occlusion of chorioangiopagous vessels (FLOC) for monochorionic diamniotic twins (MCDA) pregnancies complicated with twin-to-twin transfusion syndrome(TTTS). METHODS: The clinical data of 33 consecutive cases of TTTS from Mainland China, who had FLOC in the Department of Obstetrics and Gynaecology of Prince of Wales Hospital (The Chinese University of Hong Kong) from November 2003 to December 2010, were reviewed and analyzed for peri-operative complications, perinatal outcomes and fetal survival rate. Clinical stage of TTTS was according to the Quintero staging system. RESULTS: (1) Pregnancy characteristics: the mean maternal age was 30; the median gestational age at FLOC was 23(+4) weeks; according to the Quintero staging system, 3 cases were Quintero staging I, 14 cases were Quintero staging II, 7 cases were Quintero staging III and 9 cases were Quintero staging IV. For the 3 stage I cases, FLOC was performed for severe maternal symptoms of polyhyramnios or severe fetal cardiac dysfunction. (2) COMPLICATIONS: intraoperative complications occurred in 5 patients including four uterine bleedings at the puncture site, one placental vascular anastomosis bleeding. Postoperative complications occurred in 6 patients including 2 abortions and 1 intrauterine death within one week after operation, 2 abortions and 1 amniotic band syndrome occurred from two to four weeks after operation. (3) Perinatal outcome and fetal survival rate: the median interval of 33 patients between FLOC and delivery was 9(+4) weeks; the median gestational age at delivery was 31(+6) weeks; the gestation at delivery was less than 24 weeks in 6% (2/33), 24 to 28 weeks in 21% (7/33), 28 to 32 weeks in 18% (6/33), 32 to 37 weeks in 55% (18/33). The mean birth weight of the donor was 1600 g (350 - 2520 g); the mean birth weight of the recipiert was 1930 g (400 - 3040 g). The overall survival rate, the double infant survival rate, the single survival rate and survival rate for at least one twin was 59% (39/66), 52% (17/33), 15% (5/33) and 67% (22/33), respectively. The overall survival rate dropped from 61% (17/28) in Quintero staging II to 9/18 in Quintero staging IV. CONCLUSIONS: FLOC for MCDA complicated with TTTS is associated with an overall survival of about 60%. Major complications are rare. The outcome is not only related to Quintero staging but also the close monitoring and timely termination of pregnancy.
Asunto(s)
Transfusión Feto-Fetal/cirugía , Fetoscopía , Coagulación con Láser/métodos , Gemelos Monocigóticos , Adulto , Femenino , Transfusión Feto-Fetal/mortalidad , Transfusión Feto-Fetal/patología , Edad Gestacional , Humanos , Complicaciones Intraoperatorias/epidemiología , Persona de Mediana Edad , Complicaciones Posoperatorias/epidemiología , Embarazo , Complicaciones del Embarazo/mortalidad , Complicaciones del Embarazo/patología , Complicaciones del Embarazo/cirugía , Resultado del Embarazo , Segundo Trimestre del Embarazo , Embarazo Gemelar , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Tasa de Supervivencia , Resultado del Tratamiento , Adulto JovenRESUMEN
OBJECTIVE: To establish the normal reference range of fetal nuchal translucency (NT) thickness in Kunming Chinese pregnant women in the first trimester. METHODS: The study samples comprised of 1790 Kunming pregnant women who attended antenatal visit in the first trimester in the First Affiliated Hospital of Kunming Medical University. The general information including maternal date of birth, past pregnant history and other related conditions were recorded. The crown rump length (CRL) and NT thickness at 11 - 13(+6) gestational weeks were measured according to guidelines from Fetal Medicine Foundation (FMF). RESULTS: The total 1790 of normal fetuses was recruited for final analysis. The mean and median values of CRL were (59.6 ± 9.2) mm and 58.3 mm, respectively. The mean and median values of NT thickness were (1.7 ± 0.5) mm and 1.7 mm, respectively. While the CRL were at between 45.0 - 54.9 mm, 55.0 - 64.9 mm, 65.0 - 74.9 mm and 75.0 - 84.0 mm, the corresponding values of NT thickness were 1.0 mm, 1.3 mm, 1.5 mm, 1.5 mm at the 5(th) percentile and 2.0 mm, 2.5 mm, 2.7 mm, 2.9 mm at the 95(th) percentile, respectively, and the corresponding medial values of NT thickness were 1.4 mm, 1.7 mm, 2.0 mm, 2.0 mm, respectively. The NT thickness had no relationship with maternal age (P > 0.05). The mean value of NT thickness was (1.8 ± 1.1) mm in male fetuses. The mean value of NT thickness was (1.7 ± 0.6) mm in female fetuses. The NT thickness in male fetuses was significantly thicker than that of females (P = 0.001). CONCLUSION: The present study established a reference range of normal fetal NT thickness corresponding with CRL in early pregnancy with reliable FMF quality control.
Asunto(s)
Largo Cráneo-Cadera , Síndrome de Down/diagnóstico por imagen , Feto/anatomía & histología , Medida de Translucencia Nucal/normas , Adulto , China , Síndrome de Down/diagnóstico , Femenino , Edad Gestacional , Humanos , Medida de Translucencia Nucal/estadística & datos numéricos , Embarazo , Primer Trimestre del Embarazo , Valores de Referencia , Factores de Tiempo , Ultrasonografía Prenatal/métodosRESUMEN
OBJECTIVE: To determine if placental location in the second trimester of pregnancy is associated with adverse pregnancy outcomes. METHODS: We performed a retrospective study on 16 236 patients having ultrasound examination at 14 to 23 weeks of gestation between 2000 and 2007. The placental location was classified into one of four groups: 'central', 'fundal', 'lateral' and 'covering Os'. Obstetric outcomes of non-central placenta were compared to those with 'central' placenta. RESULTS: Women with a 'fundal' placenta were at increased risk of developing pre-eclampsia (PET) (odds ratios (OR) = 2.27; 95% confidence intervals (CI), 1.31-3.93), a preterm delivery before 34 weeks (OR = 2.23; 95% CI, 1.18-4.22), a non-vertex presentation (OR = 3.48; 95% CI, 2.49-4.86), undergoing a manual removal of placenta (MROP) following a vaginal delivery (OR = 7.1; 95% CI, 4.24-11.85) and small for gestational age (SGA) (OR = 1.35; 95% CI, 1.03-1.79). Women with a 'lateral' placenta were at increased risk of developing PET (OR = 2.04; 95% CI, 1.28-3.25), spontaneous preterm delivery before 34 weeks (OR = 2.04; 95% CI, 1.04-3.98), MROP (OR = 6.75; 95% CI, 4.4-10.33) and SGA (OR = 1.82; 95% CI, 1.48-2.23). Five women with a 'cover Os' placenta had an increased risk of postpartum haemorrhage (>1000 mL) (OR = 6.18; 95% CI 2.29-16.65) if they had a vaginal delivery. CONCLUSION: Non-central placental location in the second trimester is associated with an increase risk of adverse obstetric outcome.
Asunto(s)
Placenta/fisiología , Resultado del Embarazo , Segundo Trimestre del Embarazo/fisiología , Adulto , Parto Obstétrico/métodos , Parto Obstétrico/estadística & datos numéricos , Femenino , Humanos , Recién Nacido , Placenta/citología , Placenta/diagnóstico por imagen , Preeclampsia/diagnóstico por imagen , Preeclampsia/epidemiología , Embarazo , Complicaciones del Embarazo/diagnóstico por imagen , Complicaciones del Embarazo/epidemiología , Resultado del Embarazo/epidemiología , Estudios Retrospectivos , Ultrasonografía Prenatal , Útero/diagnóstico por imagen , Adulto JovenRESUMEN
INTRODUCTION AND HYPOTHESIS: This work aims to study the prevalence of hydronephrosis and its associated factors in women with pelvic organ prolapse (POP) and to assess the effect on hydronephrosis following treatment for POP. METHODS: In this prospective observational study, 233 patients with POP were staged by the Pelvic Organ Prolapse-Quantification system, followed by sonographic measurement of bilateral renal pelvis to identify presence of hydronephrosis. Follow-up scan for hydronephrosis was performed after patients were treated for the POP. RESULTS: The prevalence of hydronephrosis was 10.3% (95% confidence interval (CI), 6% and 14%). Although patient's age, higher parity, and the presence of diabetes mellitus and hypertension were more common in the group with hydronephrosis, logistic regression analysis indicated that only the severity of POP was an independent risk factor for hydronephrosis. The odds ratio in stages 3 to 4 POP for hydronephrosis was 3.4 (95% CI, 1.3 and 9.2). Hydronephrosis resolved in 95% of patients after they received treatment for POP. CONCLUSIONS: The prevalence of hydronephrosis was 10.3% in patients with POP and patients with stages 3 to 4 POP were at particular higher risk. Hydronephrosis resolved in most of the patients after treatment for the prolapse.
Asunto(s)
Hidronefrosis/diagnóstico por imagen , Hidronefrosis/epidemiología , Prolapso de Órgano Pélvico/complicaciones , Prolapso de Órgano Pélvico/terapia , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Terapia por Ejercicio , Femenino , Estudios de Seguimiento , Procedimientos Quirúrgicos Ginecológicos , Humanos , Persona de Mediana Edad , Pesarios , Prevalencia , Estudios Prospectivos , Análisis de Regresión , Estudios Retrospectivos , Factores de Riesgo , Resultado del Tratamiento , UltrasonografíaRESUMEN
OBJECTIVE: To assess the knowledge on commercial cord blood banking (CCBB) among pregnant women. DESIGN: Cross-sectional survey. Setting. Antenatal clinics of two major public maternity units in Hong Kong. POPULATION: Pregnant women. METHODS: Self-administered questionnaire. MAIN OUTCOME MEASURES: The survey explored knowledge about the use of self-stored umbilical cord blood (UCB) stem cells and attitude towards CCBB. RESULTS: Of the 2,000 women recruited, 1 866 (93.3%) completed the questionnaire. The majority (78.2%) had no idea that there was the chance of using self-stored stem cells. Moreover, most of the respondents were unclear about which diseases other than leukemia are amenable to treatment with UCB stem cells in general. Only 20.3% of women knew that stem cells are available from the Red Cross in case their children need hematopoietic cell transplantation. CONCLUSIONS: The results of this study revealed inadequate knowledge on UCB stem cell banking and its applications among most of our pregnant women. The government and clinicians should combine efforts to provide accurate information on utilization of UCB stem cells during antenatal care.
Asunto(s)
Bancos de Sangre , Comprensión , Sangre Fetal , Conocimiento , Mujeres Embarazadas , Trasplante de Células Madre de Sangre del Cordón Umbilical , Estudios Transversales , Recolección de Datos , Femenino , Hong Kong , Humanos , Embarazo , Encuestas y CuestionariosRESUMEN
Microcephaly and microphthalmia are both rare congenital abnormalities, while concurrently, these two are even rarer. The underlying etiology would be complex interplaying between heterogeneous genetic background and the environmental pathogens, particularly during critical periods of early tissue development. Here, we reported a prenatal case with microcephaly, microphthalmia, and bilateral cataracts detected by ultrasonography and confirmed by autopsy. Various routine infection-related tests and invasive genetic testing were negative. Whole genome sequencing of fetus and parents revealed OCLN gene defects may be associated with these multiple congenital abnormalities.